Siegfried Posts Higher Earnings and Flat Sales

Siegfried (Zofingen, Switzerland) posted a 33% increase in Ebit for the first half of this year, to SF28.5 million   ($25.7million) on sales up 1%, to SF160 million. Earnings benefited from the sale of a pharmaceutical facility at Zofingen to Arena Pharmaceuticals (San Diego) and license payments for a previous biogeneric project. Second-quarter figures were not disclosed. Siegfried’s active ingredients division reported Ebit of SF1.7 million, “clearly lower than last year,” due partly to a one-time payment of SF9.1 million made by...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers